Stock Information

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the
  • TSX Venture Exchange (TLT: TSXV)

Data last updated on October 1, 2020

Number of common shares outstanding

Share Price: C$0.14

Warrants: 72,473,931

Shares Outstanding: 204,275,375

Stock Options: 14,500,000

Fully Diluted: 291,249,306

For Investor Relations please contact: Investor Information Theralase®

Our Partners

As part of our continuing mission to design, develop, and manufacture cutting-edge laser technologies, Theralase® has partnered with individuals and groups at the following institutions and organizations.